Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BBY vs GSK✓SelectedUSD · GSKBBY vs GSK performance historyLatest closeAs of-0.69%11/16
Stock and ETF performance explorer

BBY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+83,964.9%
GSK return
+1,741.1%
Excess return
+82,223.8%
Maximum drawdown
-80.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.6%-0.7%
7D-2.8%-1.3%-1.4%-2.3%
30D+11.6%+2.7%+8.8%+10.6%
3M+20.8%+2.7%+18.1%+19.8%
6M+88.0%+3.3%+84.7%+85.2%
YTD+60.5%+6.5%+54.1%+55.6%
1Y+43.8%+10.7%+33.1%+37.4%
3Y+79.2%+64.4%+14.8%+44.4%
5Y-3.3%+46.7%-50.0%-20.3%
10Y+267.4%+109.4%+158.1%+161.5%
All+83,964.9%+1,741.1%+82,223.8%+29,245.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling